Table 1.
Basic and clinical characteristics of the patients with or without cholelithiasis who underwent PEG insertion.
| All (n = 574) | Non-cholelithiasis (n = 413) | Cholelithiasis (n = 161) | p value | |
|---|---|---|---|---|
| Age (years, SD) | 67.48 (14.28) | 66.11 (14.26) | 70.97 (13.79) | < 0.01 |
| Sex (female), n (%) | 164 (28.9) | 116 (28.50) | 48 (29.80) | 0.756 |
| BMI (kg/m2, SD) | 19.89 (3.70) | 19.70 (3.54) | 20.26 (4.01) | 0.154 |
| PEG cause, n (%) | ||||
| Dementia, old age | 75 (13.1) | 33 (8) | 42 (13.1) | |
| Brain damage | 237 (41.5) | 162 (39.5) | 75 (46.6) | |
| Oropharyngeal or esophageal cancer or abnormality | 119 (20.8) | 94 (22.9) | 25 (15.5) | |
| Lung disease | 22 (3.9) | 18 (4.4) | 4 (2.5) | |
| Others | 118 (20.7) | 103 (25.1) | 15 (9.3) | |
| Underlying disease, n (%) | ||||
| DM | 153 (27) | 100 (24.5) | 53 (33.3) | 0.03 |
| HTN | 251 (44.3) | 177 (43.4) | 74 (46.5) | 0.496 |
| ESRD | 17 (3.0) | 7 (1.7) | 10 (6.3) | 0.004 |
| CAOD, CHF | 44 (7.8) | 33 (8.1) | 11 (6.9) | 0.629 |
| LC | 4 (0.7) | 2 (0.5) | 2 (1.3) | 0.327 |
| Malignancy | 172 (30.3) | 128 (31.4) | 44 (27.3) | 0.335 |
| Laboratory findings, mean (median) | ||||
| WBC (×1000) | 8.87 (5.01) | 8.23 (3.83) | 10.52 (6.97) | < 0.01 |
| Hemoglobin (g/dL) | 11.21 (2.14) | 11.62 (6.70) | 11.29 (2.36) | 0.562 |
| Total bilirubin (mg/dL) | 0.77 (3.75) | 0.75 (4.32) | 0.81 (1.31) | 0.865 |
| AST (IU/L) | 33.24 (52.254) | 27.90 (22.52) | 47.12 (90.95) | < 0.01 |
| ALT (IU/L) | 28.36 (46.48) | 23.67(23.09) | 40.55(78.84) | < 0.01 |
| ALP (IU/L) | 174.69 (195.79) | 164 (163.47) | 203.39 (262.22) | 0.088 |
| BUN (mg/dL) | 20.949 (17.63) | 18.49 (13.04) | 27.57 (25.15) | < 0.01 |
| Creatinine (mg/dL) | 0.95 (0.96) | 0.81 (0.73) | 1.31 (1.33) | < 0.01 |
| Total cholesterol (mg/dL) | 140.15 (43.59) | 142.44 (41.79) | 134.42 (47.46) | 0.063 |
| LDL (mg/dL) | 87.76 (47.79) | 89.39 (47.82) | 79.25 (47.76) | 0.343 |
| TG (mg/dL) | 117.03 (68.70) | 115.33 (64.21) | 125.48 (88.78) | 0.5 |
| LDH (IU/L) | 269.21 (193.21) | 264.11 (201.64) | 281.46 (171.39) | 0.397 |
| CRP (mg/dL) | 4.61 (5.64) | 3.71(4.36) | 7.05(7.68) | < 0.01 |
| Physical activity status (%) | < 0.001 | |||
| Bed-ridden | 462 (80.5) | 320 (77.5) | 142 (88.2) | |
| Involuntary walking | 23 (4.0) | 20 (4.8) | 3 (1.9) | |
| Voluntary walking | 89 (15.5) | 73 (17.7) | 16 (9.9) | |
PEG, percutaneous endoscopic gastrostomy; n, number; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; ESRD, end stage renal disease; CAOD, coronary artery obstructive disease; CHF, congestive heart failure; LC, liver cirrhosis; WBC, white blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; BUN, blood urea nitrogen; LDL, low density lipoprotein; TG, triglyceride; LDH, lactate dehydrogenase; CRP, C-reactive protein.